Trade Summary

6 months ago, Novo Holdings A/S, serving as 10% owner at Maplight Therapeutics, Inc. (MPLT), purchased 952,941 shares at $17.00 per share, for a total transaction value of $16,199,997.00. Following this transaction, Novo Holdings A/S now holds 3,686,622 shares of MPLT.

This purchase represents a 35.00% increase in Novo Holdings A/S's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, October 28, 2025 and publicly disclosed via SEC Form 4 filing on Thursday, October 30, 2025 at 4:31 PM ET, 2 days after the trade was made.

Maplight Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.